Derivative (1;7)(q10;p10) in a patient with de novo acute erythroblastic leukemia (AML-M6)

Cancer Genetics and Cytogenetics

Volumn 115, Issue 1, 1999, Pages 62-64

  Obara, Naoshi ^a   Shinagawa, Atsushi ^a   Komatsu, Tsunehiko ^a   Abe, Tsukasa ^a   Ninomiya, Haruhiko ^b  

^a Tsukuba Memorial Hospital   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; DAUNORUBICIN; MITOXANTRONE;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ARTICLE; CASE REPORT; ERYTHROLEUKEMIA; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROGNOSIS;

AGED; BONE MARROW CELLS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 7; HUMANS; KARYOTYPING; LEUKEMIA, ERYTHROBLASTIC, ACUTE; LYMPHOCYTE SUBSETS; MALE; TRANSLOCATION, GENETIC;

EID: 0033229886     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(99)00076-X     Document Type: Article

References (19)

1. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med. 103:1985;620-625.
2. Berger R., Flandrin G., Bernheim A., Le Coniat M., Vecchione D., Pacot A., Derre J., Daniel M.T., Valensi F., Sigaux F., Ochoa-Noguera M.E. Cytogenetic studies on 519 consecutive de novo acute nonlymphocytic leukemias. Cancer Genet Cytogenet. 29:1987;9-21.
3. Raimondi S.C., Dube I.D., Valentine M.B., Mirro J. Jr., Watt H.J., Larson R.A., Bitter M.A., Le Beau M.M., Rowley J.D. Clinicopathologic manifestations and breakpoints of the t(3;5) in patients with acute nonlymphocytic leukemia. Leukemia. 3:1989;42-47.
4. Nakamura H. Cytogenetic heterogeneity in erythroleukemia defined as M6 by French-American-British (FAB) Cooperative Group criteria. Leukemia. 3:1989;305-309.
5. Olopade O.I., Thangavelu M., Larson R.A., Mick R., Kowal-Vern A., Schumacher H.R., Le Beau M.M., Vardiman J.W., Rowley J.D. Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia. Blood. 80:1992;2873-2882.
6. Davey F.R., Abraham N. Jr., Brunetto V.L., MacCallum J.M., Nelson D.A., Ball E.D., Griffin J.D., Baer M.R., Wurster-Hill D., Mayer R.J., Schiffer C.A., Bloomfield C.D. Morphologic characteristics of erythroleukemia (acute myeloid leukemia; FAB-M6). a CALGB study Am J Hematol. 49:1995;29-38.
7. Morrison-DeLap S.J., Kuffel D.G., Dewald G.W., Letendre L. Unbalanced 1;7 translocation and therapy-induced hematologic disorders. a possible relationship Am J Hematol. 21:1986;39-47.
8. Yokoo H., Okada Y., Tominaga K., Tsuji M., Takagi T., Maseki N., Sakurai M., Kaneko Y. der(1;7)(q10;p10) in three patients with malignant hematologic disorders. Jpn J Clin Hematol. 33:1992;1829-1833. (in Japanese with English abstract).
9. Hamamoto K., Hashimoto-Ninomiya A., Kishimoto Y., Kimura T., Fujitake H., Yasunaga K., Horiike S. Unbalanced 1;7 translocation in myelodysplastic syndrome following acute myeloblastic leukemia with an 8;21 translocation. Cancer Genet Cytogenet. 74:1994;35-39.
10. Horiike S., Taniwaki M., Misawa S., Nishigaki H., Okuda T., Yokota S., Kashima K., Inazawa J., Abe T. The unbalanced 1;7 translocation in de novo myelodysplastic syndrome and its clinical implication. Cancer. 65:1990;1350-1354.
11. Baumgarten E., Wegner R.D., Fengler R., Koch H., Henze G. Partial trisomy 1q, an uncommon chromosomal aberration in erythroleukemia. Leuk Lymphoma. 10:1993;237-240.
12. Satoh K., Miura I., Chubach A., Utsumi S., Imai H., Miura A.B. Development of secondary leukemia associated with (1;7)(q10;p10) in a patient with Crow-Fukase syndrome. Intern Med. 35:1996;660-662.
13. Geraedts J.P.M., den Ottolander G.J., Ploem J.E., Muntinghe O.G. An identical translocation between chromosome 1 and 7 in three patients with myelofibrosis and myeloid metaplasia. Br J Haematol. 44:1980;569-575.
14. Pedesen-Bjergaard J., Oreben P. Cytogenetic characteristics of therapy-related acute non-lymphocytic leukaemia, preleukemia and acute myeloproliferative syndrome. correlation with clinical data for 61 consecutive cases Br J Haematol. 66:1987;199-207.
15. Kere J., Ruutu T., Davies K.A., Roninson I.B., Watkins P.C., Winqvist R., de la Chapelle A. Chromosome 7 long arm deletion myeloid disorders. a narrow breakpoint region in 7q22 defined by molecular mapping Blood. 85:1989;230-234.
16. Stanley W.S., Burkett S.S., Segel B., Quiery A., George B., Lobel J., Shah N. Constitutional inversion of chromosome 7 and hematologic cancers. Cancer Genet Cytogenet. 96:1997;46-49.
17. Woloschak G.E., Dewald G.W., Bahm R.S., Kyle R.A., Greipp P.R., Debray J. Amplification of RNA and DNA specific for erb-B in unbalanced 1;7 chromosomal translocation associated with myelodysplastic syndrome. J Cell Biochem. 32:1985;23-34.
18. Liang H., Fairman J., Claxton J., Nowell P.C., Green E.D., Nagarajan L. Molecular anatomy of chromosome 7q deletions in myeloid neoplasms. evidence for multiple critical loci Proc Natl Acad Sci USA. 95:1998;3781-3785.
19. Alitalo T., Willard H.F., de la Chapelle A. Determination of the breakpoint of 1;7 translocation in myelodysplastic syndrome by in situ hybridization using chromosome specific alpha satellite DNA from human chromosome 1 and 7. Cytogenet Cell Genet. 50:1989;49-53.